NEW DELHI: In an attempt to revamp drug price regulation in the country, while strengthening implementation and market monitoring, the government is set to restructure the regulator, National Pharmaceutical Pricing Authority (NPPA).
The authority, which is expected to be re-christened soon, will be replaced by a board or a council with four full-time members, including the chairman. The other three members — an economist, a costing specialist and a technology expert — will also hold a rank similar to the chairman, according to a proposal being considered at the highest level of the government.
"The proposal was floated by Niti Aayog and discussed in a meeting with the PMO. Largely, there is a consensus on this within the government and therefore, we are expecting a notification by end of this month," a government official said.
Please click here to read more.